Lumax Industries Limited (BOM:517206)

Oncternal Therapeutics Revenue

Lumax Industries had revenue of 9.23B INR in the quarter ending June 30, 2025, with 20.47% growth. This brings the company's revenue in the last twelve months to 35.58B, up 27.79% year-over-year. In the fiscal year ending March 31, 2025, Lumax Industries had annual revenue of 34.01B with 28.96% growth.

• Revenue (ttm): 35.58B
• Revenue Growth: +27.79%
• P/S Ratio: 0.89
• Revenue / Employee: 12.12M
• Employees: 2,755
• Market Cap: 31.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	34.01B	7.64B	28.96%
Mar 31, 2024	26.37B	3.18B	13.70%
Mar 31, 2023	23.20B	5.68B	32.44%
Mar 31, 2022	17.51B	3.24B	22.73%
Mar 31, 2021	14.27B	-1.76B	-11.00%